SynthesisReviews in medical virology2022

Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients: A systematic review and meta-analysis.

Jingwen Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.